317 related articles for article (PubMed ID: 19177141)
1. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
Joly P; Roujeau JC; Benichou J; Delaporte E; D'Incan M; Dreno B; Bedane C; Sparsa A; Gorin I; Picard C; Tancrede-Bohin E; Sassolas B; Lok C; Guillaume JC; Doutre MS; Richard MA; Caux F; Prost C; Plantin P; Chosidow O; Pauwels C; Maillard H; Saiag P; Descamps V; Chevrant-Breton J; Dereure O; Hellot MF; Esteve E; Bernard P
J Invest Dermatol; 2009 Jul; 129(7):1681-7. PubMed ID: 19177141
[TBL] [Abstract][Full Text] [Related]
2. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
[TBL] [Abstract][Full Text] [Related]
3. Prediction of survival for patients with bullous pemphigoid: a prospective study.
Joly P; Benichou J; Lok C; Hellot MF; Saiag P; Tancrede-Bohin E; Sassolas B; Labeille B; Doutre MS; Gorin I; Pauwels C; Chosidow O; Caux F; Estève E; Dutronc Y; Sigal M; Prost C; Maillard H; Guillaume JC; Roujeau JC
Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914
[TBL] [Abstract][Full Text] [Related]
4. Whole body application of a potent topical corticosteroid for bullous pemphigoid.
Terra JB; Potze WJ; Jonkman MF
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654
[TBL] [Abstract][Full Text] [Related]
5. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
Zimmermann R; Faure M; Claudy A
Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
[TBL] [Abstract][Full Text] [Related]
6. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
[TBL] [Abstract][Full Text] [Related]
7. [Bullous pemphigoid: a review].
Bernard P; Charneux J
Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
[TBL] [Abstract][Full Text] [Related]
8. Topical corticosteroids and bullous pemphigoid.
Hull CM; McKenna JK; Zone JJ
Arch Dermatol; 2003 Feb; 139(2):225-6. PubMed ID: 12588236
[No Abstract] [Full Text] [Related]
9. [One year follow-up of patients with bullous pemphigoid].
Doffoel-Hantz V; Sparsa A; Marin B; Durox H; Bonnetblanc JM; Bédane C
Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795
[TBL] [Abstract][Full Text] [Related]
10. Treatment of bullous pemphigoid with topical clobetasol propionate.
Westerhof W
J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
Du-Thanh A; Merlet S; Maillard H; Bernard P; Joly P; Estève E; Richard MA; Pauwels C; Ingen-Housz-Oro S; Guillot B; Dereure O
Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
[TBL] [Abstract][Full Text] [Related]
12. Oral and topical corticosteroids in bullous pemphigoid.
Spigel GT
N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117002
[No Abstract] [Full Text] [Related]
13. Tinea incognito in an old patient with bullous pemphigoid receiving topical high potency steroids.
Liu ZH; Shen H
J Mycol Med; 2015 Sep; 25(3):245-6. PubMed ID: 26278826
[No Abstract] [Full Text] [Related]
14. Bullous pemphigoid treated by topical corticosteroids.
Paquet P; Richelle M; Lapiere CM
Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
[TBL] [Abstract][Full Text] [Related]
17. Oral and topical corticosteroids in bullous pemphigoid.
Bystryn JC; Wainwright BD; Shupack JL
N Engl J Med; 2002 Jul; 347(2):143-5; author reply 143-5. PubMed ID: 12117001
[No Abstract] [Full Text] [Related]
18. Assessment of hydro-saline retention in bullous pemphigoid patients treated with super-potent topical corticosteroids.
Hébert V; Duvert-Lehembre S; Deschamps-Huvier A; Vannier M; Thill C; Joly P
Ann Dermatol Venereol; 2023 Mar; 150(1):35-38. PubMed ID: 36257854
[TBL] [Abstract][Full Text] [Related]
19. Management of bullous pemphigoid with topical steroids in the clinical practice of a single center: outcome at 6 and 12 months.
Ingen-Housz-Oro S; Valeyrie-Allanore L; Ortonne N; Roujeau JC; Wolkenstein P; Chosidow O
Dermatology; 2011; 222(2):176-9. PubMed ID: 21447939
[TBL] [Abstract][Full Text] [Related]
20. Clobetasol propionate spray 0.05% add-on therapy to a stable regimen of biologic treatment in patients with moderate to very severe plaque psoriasis.
Feldman SR; Koo JY; Johnson LA; Preston NJ
Cutis; 2009 Oct; 84(4 Suppl):25-32. PubMed ID: 19916299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
